Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

BVMed leaflet on apheresis:

This article was originally published in Clinica

Executive Summary

The benefits of therapeutic apheresis are described in a new brochure from BVMed, the German industry association for medical devices. The 32-page document describes apheresis as an innovative, extra-corporeal blood filtration procedure for eliminating certain toxins with very few side effects. "Therapeutic apheresis offers many medical disciplines the ability to provide a non-traumatic therapy which can be optimally adapted to the treatment of the individual," says BVMed. The association agreed to represent companies in the area of therapeutic apheresis in November last year (see Clinica No 943, p 6).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT070296

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel